Cost Benefit Assessment of Pharmaceutical Products

Karl E. Peace, Harvey Zimmerman

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

This article was published in Therapeutic Innovation and Regulatory Science.
Original languageAmerican English
JournalTherapeutic Innovation and Regulatory Science
Volume22
DOIs
StatePublished - Jul 1 1988

Keywords

  • Cost benefit assessment
  • Pharmaceutical products

DC Disciplines

  • Public Health
  • Biostatistics

Fingerprint

Dive into the research topics of 'Cost Benefit Assessment of Pharmaceutical Products'. Together they form a unique fingerprint.

Cite this